Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical NSAID plus steroid versus steroid alone after endothelial keratoplasty
2020-003408-15Phase 4Active
- Sponsor
- Oslo University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in keratopathy and corneal fibrosis comparing Nevanac + Spersadex with Spersadex alone (2 arms). Primary endpoints: Central macular thickness and Macular cysts. Started Apr 2021; status: active.
02
Drugs
nepafenacHiDex
03
Conditions
keratopathycorneal fibrosis
Beyond the preview
Go deeper on 2020-003408-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003408-15.